LRRK2 and inflammatory bowel disease: This pattern of expression may be put into relation with the finding that genetic association studies have found LRRK2 to be a risk factor for inflammatory bowel disease (Crohn’s disease, CD) (e.g., Derkinderen and Neunlist, 2018; Hui et al., 2018; Ridler, 2018).